drugset / Trial / NCT01439230

Donepezil 10 mg Tablets Under Fasting Conditions

NCT01439230

Phase 1 Completed 36 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-label

Summary

The objective of this study was to compare the rate and extent of absorption of donepezil 10 mg tablet (test) versus Aricept® (reference), administered as a 1 x 10 mg tablet under fasting conditions.

Timeline

Start
2007-06
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg

Indications

No indication recorded.